NTRB (Nutriband) Short Interest


NTRB Nutriband Inc NTRB
61 GF Score
Price $3.07
GF Value $3.25
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Nutriband Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NTRB vs KALA, RNXT, NNVC: Short Interest Comparison

For the Biotechnology subindustry, Nutriband's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nutriband Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nutriband's Short Interest distribution charts can be found below:

* The bar in red indicates where Nutriband's Short Interest falls into.


NTRB
61GF Score
Nutriband Inc NTRB
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nutriband (NTRB) Overvalued in 2026?

Based on GuruFocus' analysis, Nutriband stock appears to be undervalued. The current stock price of $3.07 is trading 5.5% below its estimated GF Value™ of $3.25. GuruFocus considers Nutriband to be Fairly Valued.

Key valuation signals for NTRB:

  • Short Interest:
  • GF Value™: $3.25 vs. price of $3.07 (5.5% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the NTRB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nutriband Business Description

Address 121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
61GF Score

Get the complete analysis for NTRB

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.07
Price
$3.25
GF Value